Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 19 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 19, Issue 2 (June 2016) In this issue Reviews Original Articles Corrigendum Also new AOP Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Advertisement Take a look at our new Editor's Choice page  Prostate Cancer and Prostatic Diseases is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful.  See the latest Editor's Choice articles   Reviews Top Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science OPEN N Nussbaum, D J George, A P Abernethy, C M Dolan, N Oestreicher, S Flanders and T B Dorff Prostate Cancer Prostatic Dis 2016 19: 111-121; advance online publication, February 2, 2016; 10.1038/pcan.2015.42 Abstract | Full Text Body mass index and mortality in prostate cancer patients: a dose–response meta-analysis S Zhong, X Yan, Y Wu, X Zhang, L Chen, J Tang and J Zhao Prostate Cancer Prostatic Dis 2016 19: 122-131; advance online publication, January 12, 2016; 10.1038/pcan.2015.64 Abstract | Full Text Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy A S Polackwich and D A Shoskes Prostate Cancer Prostatic Dis 2016 19: 132-138; advance online publication, March 8, 2016; 10.1038/pcan.2016.8 Abstract | Full Text Chemotherapy for metastatic castrate-sensitive prostate cancer R E Miller and C J Sweeney Prostate Cancer Prostatic Dis 2016 19: 139-144; advance online publication, March 15, 2016; 10.1038/pcan.2016.10 Abstract | Full Text Original Articles Top Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer B A Rybicki, O N Kryvenko, Y Wang, M Jankowski, S Trudeau, D A Chitale, N S Gupta, A Rundle and D Tang Prostate Cancer Prostatic Dis 2016 19: 145-150; advance online publication, December 1, 2015; 10.1038/pcan.2015.54 Abstract | Full Text Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis A D Raval, D Thakker, H Negi, A Vyas and M W Salkini Prostate Cancer Prostatic Dis 2016 19: 151-162; advance online publication, January 19, 2016; 10.1038/pcan.2015.58 Abstract | Full Text The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy S Sevcenco, R Mathieu, P Baltzer, T Klatte, H Fajkovic, C Seitz, P I Karakiewicz, M Rouprêt, M Rink, L Kluth, Q-D Trinh, W Loidl, A Briganti, D S Scherr and S F Shariat Prostate Cancer Prostatic Dis 2016 19: 163-167; advance online publication, January 26, 2016; 10.1038/pcan.2015.60 Abstract | Full Text In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI K C McCammack, C J Kane, J K Parsons, N S White, N M Schenker-Ahmed, J M Kuperman, H Bartsch, R S Desikan, R A Rakow-Penner, D Adams, M A Liss, R F Mattrey, W G Bradley, D J A Margolis, S S Raman, A Shabaik, A M Dale and D S Karow Prostate Cancer Prostatic Dis 2016 19: 168-173; advance online publication, January 12, 2016; 10.1038/pcan.2015.61 Abstract | Full Text Variation in prostate cancer treatment associated with population density of the county of residence C Cary, A Y Odisho and M R Cooperberg Prostate Cancer Prostatic Dis 2016 19: 174-179; advance online publication, January 19, 2016; 10.1038/pcan.2015.65 Abstract | Full Text Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study D M Moreira, J C Nickel, G L Andriole, R Castro-Santamaria and S J Freedland Prostate Cancer Prostatic Dis 2016 19: 180-184; advance online publication, January 19, 2016; 10.1038/pcan.2015.66 Abstract | Full Text Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy G Gandaglia, G Lista, N Fossati, N Suardi, A Gallina, M Moschini, L Bianchi, M S Rossi, R Schiavina, S F Shariat, A Salonia, F Montorsi and A Briganti Prostate Cancer Prostatic Dis 2016 19: 185-190; advance online publication, February 9, 2016; 10.1038/pcan.2016.1 Abstract | Full Text The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism M Shiota, N Fujimoto, A Yokomizo, A Takeuchi, E Kashiwagi, T Dejima, K Kiyoshima, J Inokuchi, K Tatsugami and M Eto Prostate Cancer Prostatic Dis 2016 19: 191-196; advance online publication, February 9, 2016; 10.1038/pcan.2016.2 Abstract | Full Text Common variation in BRCA1 may have a role in progression to lethal prostate cancer after radiation treatment A Sanchez, J D Schoenfeld, P L Nguyen, M Fiorentino, D Chowdhury, M J Stampfer, H D Sesso, E Giovannucci, L A Mucci and I M Shui Prostate Cancer Prostatic Dis 2016 19: 197-201; advance online publication, March 1, 2016; 10.1038/pcan.2016.4 Abstract | Full Text Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE S Fischer, S Sun, L E Howard, D M Moreira, R Castro-Santamaria, G L Andriole, A C Vidal and S J Freedland Prostate Cancer Prostatic Dis 2016 19: 202-208; advance online publication, March 1, 2016; 10.1038/pcan.2016.5 Abstract | Full Text Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy Y Wang, W Yin, Z Wang, J Huang, J Pan, Y Zhu, F Xu, X Shao, J Sha, Y Cai, Q Liu, B Dong, W Xue and Y Huang Prostate Cancer Prostatic Dis 2016 19: 209-215; advance online publication, March 8, 2016; 10.1038/pcan.2016.6 Abstract | Full Text Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy T M Morgan, S R Hawken, K R Ghani, D C Miller, F Y Feng, S M Linsell, J A Salisz, Y Gao, J E Montie and M L Cher for the Michigan Urological Surgery Improvement Collaborative Prostate Cancer Prostatic Dis 2016 19: 216-221; advance online publication, March 8, 2016; 10.1038/pcan.2016.9 Abstract | Full Text Corrigendum Top Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis A D Raval, D Thakker, H Negi, A Vyas and M W Salkini Prostate Cancer Prostatic Dis 2016 19: 222; advance online publication, February 9, 2016; 10.1038/pcan.2016.3 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.